VALENTINA LEFANTE: Open Payments
NPI 1083286629 · HAZLET, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,876 in 88 payments from 18 companies in 2025. Trend: 2023 $917 · 2024 $851 · 2025 $1,876
Food & beverage: $1,651Education: $225
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $297 |
| Inspire Medical Systems, Inc. | 5 | $233 |
| GlaxoSmithKline, LLC. | 16 | $202 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $163 |
| GENZYME CORPORATION | 9 | $152 |
| HARMONY BIOSCIENCES LLC | 4 | $142 |
| Verona Pharma, Inc. | 7 | $111 |
| Axsome Therapeutics, Inc. | 5 | $94 |
| Viatris Specialty LLC | 5 | $88 |
| Actelion Pharmaceuticals US, Inc. | 2 | $81 |
Products named: DUPIXENT, INSPIRE, LUMRYZ, NUCALA, TEZSPIRE, Ohtuvayre, Sunosi, YUPELRI.
Industry payments across NJ — which companies pay providers there.
